The expression of ALAS2 and HMBS involved in iron utilization was associated with improved PFS in ovarian cancer, whereas expression of ABCB7, ALAD, FXN, UROS, ISCU, and CPOX in this process was associated with poor PFS in ovarian cancer (Table 2). Here, ALAS2 is linked to ovarian carcinoma.